Revenues Increase 11.7% for New Record Quarter
![Simulations Plus Reports First Quarter FY2013 Financial Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports First Quarter FY2013 Financial Results
Net sales increase 1.9% to first-quarter record $2.290 million; Earnings per share $0.04
![Simulations Plus Announces Accelerated Quarterly Cash Dividend](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Announces Accelerated Quarterly Cash Dividend
Company declares accelerated cash dividend of $0.14 per share
![Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter FY2013](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter FY2013
Revenues Increase 1.9% for New Record 1st Quarter
![Simulations Plus Reports FY2012 and Fourth Quarter FY2012 Financial Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports FY2012 and Fourth Quarter FY2012 Financial Results
Fiscal Year Pharmaceutical Software and Services Up 8.1%, EPS Up 11.1%
![Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2012 Earnings Release and Conference Call](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2012 Earnings Release and Conference Call
Conference Call to be on Monday, November 19, 2012, at 4:15 PM EST
![Simulations Plus Announces Next Quarterly Cash Dividend](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Announces Next Quarterly Cash Dividend
Company declares cash dividend of $0.05 per share
![Simulations Plus Joins European Consortium on Development of Oral Bioavailability Tools (OrBiTo)](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Joins European Consortium on Development of Oral Bioavailability Tools (OrBiTo)
Simulations Plus is the only non-European company invited to consortium
![Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter and FY2012](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter and FY2012
Pharmaceutical Software and Services Revenues Increase 14.9% for Record 4th Quarter, up 8.1% for the Record Fiscal Year
![Simulations Plus Announces Next Quarterly Cash Dividend](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Announces Next Quarterly Cash Dividend
Company declares cash dividend of $0.05 per share
![Simulations Plus Reports 3rd Quarter and First 9 Months FY2012 Financial Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports 3rd Quarter and First 9 Months FY2012 Financial Results
3rd quarter sales increase 5.0% to $2.77 million; 9 months net income up 5.9% to $2.68 million
![Simulations Plus Sets Date for 3rd Quarter 2012 Earnings Release and Conference Call](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Sets Date for 3rd Quarter 2012 Earnings Release and Conference Call
Conference Call to Be on Thursday, July 12, at 4:15 PM ET
![Simulations Plus Expands Marketing and Sales Staff](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Expands Marketing and Sales Staff
Ms. Anu Sharma Joins the Company as Senior Sales and Marketing Manager, focusing on Cheminformatics Products
![Simulations Plus Signs Additional Collaboration Agreement](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Signs Additional Collaboration Agreement
Major Pharmaceutical Company to Fund Transdermal and Subcutaneous Drug Absorption Model in GastroPlus
![Simulations Plus Signs Collaboration Agreement](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Signs Collaboration Agreement
Major Pharmaceutical Company to Fund Enhanced Oral Cavity Model in GastroPlus™
![Simulations Plus Reports Preliminary Third Quarter FY2012 Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports Preliminary Third Quarter FY2012 Results
Net sales increase 4.9% to new 3rd quarter record of $2.77 million
![Simulations Plus (SLP) Releases MedChem Studio 3.0 and MedChem Designer 2.0](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus (SLP) Releases MedChem Studio 3.0 and MedChem Designer 2.0
Molecule Design Tools Used in Company’s Malaria Drug Design Project Released
![Simulations Plus (SLP) Releases GastroPlus™ 8.0](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus (SLP) Releases GastroPlus™ 8.0
Major New Upgrade Increases Power of Its Best-in-Class Software